AQST
Aquestive Therapeutics, Inc.
Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
12
Buys
5
Sells
6
Largest Trade
$500K+
Insiders
5
Institutional Funds
135
Inst. Value
$1M+
Activist Filings
9
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Barber Daniel | President and CEO | SELL | $500K+ | 91K | $6.03 | Sep 29, 2025 |
| Boyd Peter E. | See Remarks | SELL | $50K–$100K | 10K | $6.30 | Sep 29, 2025 |
| Barber Daniel | President and CEO | SELL | $1K–$15K | 400 | $6.00 | Sep 22, 2025 |
| Jung Cassie | COO | SELL | $100K–$500K | 62K | $5.00 | Sep 8, 2025 |
| Jung Cassie | COO | EXERCISE | $50K–$100K | 50K | $1.93 | Sep 8, 2025 |
| Boyd Peter E. | See Remarks | SELL | $50K–$100K | 15K | $5.30 | Sep 8, 2025 |
| Jung Cassie | COO | SELL | <$1K | 44 | $4.87 | Nov 27, 2024 |
| Boyd Peter E. | SVP-Bus. Process &… | BUY | $1K–$15K | 5K | $0.81 | Jun 15, 2022 |
| Barber Daniel | CEO | BUY | $50K–$100K | 92K | $0.96 | Jun 10, 2022 |
| Schobel Alexander Mark | Chief Innovation/T… | BUY | $15K–$50K | 46K | $0.96 | Jun 10, 2022 |
| Boyd Peter E. | SVP-Bus. Process &… | BUY | $1K–$15K | 2K | $0.96 | Jun 10, 2022 |
| BRAENDER LORI J | General Counsel | BUY | $1K–$15K | 14K | $0.96 | Jun 10, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 135 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Samsara BioCapital, LLC | 2.5M | $1M+ | SH |
| STATE STREET CORP | 2.5M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 1.2M | $1M+ | SH |
| WELLS FARGO & COMPANY/MN | 1.1M | $1M+ | SH |
| Janney Montgomery Scott LLC | 1.1M | $1M+ | SH |
| COMMONWEALTH EQUITY SERVICES, LLC | 1.0M | $1M+ | SH |
| HRT FINANCIAL LP | 995K | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 971K | $1M+ | SH |
| Aberdeen Group plc | 809K | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 747K | $1M+ | SH |
| WASATCH ADVISORS LP | 681K | $1M+ | SH |
| Blue Owl Capital Holdings LP | 525K | $1M+ | SH |
| Blue Owl Capital Holdings LP | 525K | $1M+ | SH |
| Ikarian Capital, LLC | 500K | $1M+ | SH (Put) |
| RENAISSANCE TECHNOLOGIES LLC | 414K | $1M+ | SH |
| BARCLAYS PLC | 341K | $1M+ | SH |
| JPMORGAN CHASE & CO | 325K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 302K | $1M+ | SH |
| Walleye Capital LLC | 288K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Nov 14, 2025
5.2%
6.3M shares
SC 13G/A · Oct 17, 2025
5.3%
6.4M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Feb 14, 2025
2.9%
2.6M shares
SC 13G/A · Feb 13, 2025
11.1%
10.1M shares
SC 13G/A · Nov 14, 2024
2.9%
2.8M shares
SC 13G · Nov 8, 2024
6.4%
5.8M shares
SC 13G · Oct 22, 2024
6.4%
5.8M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G · Apr 1, 2024
6.5%
5.6M shares
SC 13G · Feb 14, 2024
5.9%
3.9M shares